Resources

Selected
  • Mpox
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
55 results found
2025 ∙ Yeshiwas, A. G. Tsega, T. D. Denku, C. Y. Jember, M. N. Aynalem, Z. B. Ayalew, M. D. Wondimu, A. T. Alemu, A. S. Tessema, M. T. Mehari, M. G. Berihun, S. Bayeh, G. M.
Mpox vaccine acceptance and its predictors among people who have risky sexual practices: A systematic review and meta-analysis
All age groups Mpox Acceptance
Rating:
Not applicable
2025 ∙ Yappalparvi, A. Gaidhane, S. Padmapriya, G. Kaur, I. Lal, M. Iqbal, S. Prasad, G. V. S. Pramanik, A. Sharma, P. Malik, P. Vishwakarma, T. Punia, A. Jagga, M. Mehta, R. Sah, S. Shabil, M. Satapathy, P. Bushi, G. Parsa, A. D. Kabir, R.
Prevalence of Mpox Vaccine Acceptance Among Students: A Systematic Review and Meta-Analysis
Adolescents Adults Mpox Acceptance
Rating:
Not applicable
2025 ∙ Yappalparvi, A. Khatib, M. N. Balaraman, A. K. Rekha, M. M. Kaur, M. Sharma, G. C. Sudan, P. Naidu, K. S. Singh, R. Ramashankar, S. Khati, K. Chauhan, S. S. Verma, L. Sidhu, A. Mehta, R. Sah, R. Gaidhane, A. M. Shabil, M. Chipeta, J. C. Bushi, G.
Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis
All age groups Mpox Acceptance
Rating:
Not applicable
2025 ∙ Ugwu, C. L. J. Bragazzi, N. L. Wu, J. Kong, J. D. Asgary, A. Orbinski, J. Woldegerima, W. A.
Risk factors associated with human Mpox infection: A systematic review and meta-Analysis
All age groups Mpox Efficacy/effectiveness
Rating:
Low
2025 ∙ SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, March 2025: Conclusions and recommendations
Meeting report Pneumococcal disease Mpox Herpes zoster Poliomyelitis
Download:
2025 ∙ Folkhälsomyndigheten
Vaccination against mpox – a second update of vaccine recommendations due to increased spread of mpox clade 1
Recommendation Europe Sweden Mpox
Download:
2024 ∙ Tanashat, M. Altobaishat, O. Sharaf, A. Hossam El Din Moawad, M. Al-Jafari, M. Nashwan, A. J.
Assessment of the knowledge, attitude, and perception of the world's population towards monkeypox and its vaccines: A systematic review and descriptive analysis of cross-sectional studies
All age groups Healthcare workers Mpox Acceptance
Rating:
Not applicable
2024 ∙ Taha, A. M. Mahmoud, A. M. Abouelmagd, K. Saed, S. A. A. Khalefa, B. B. Shah, S. Satapathy, P. Shamim, M. A. Sah, S. Serhan, H. A. Donovan, S. Sah, R. Barboza, J. J.
Effectiveness of a single dose of JYNNEOS vaccine in real world: A systematic review and meta-analysis
All age groups Mpox Efficacy/effectiveness
Rating:
Low
2024 ∙ Liu, H. Wang, W. Zhang, Y. Wang, F. Duan, J. Huang, T. Huang, X. Zhang, T.
Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity
All age groups Mpox Efficacy/effectiveness Safety
Rating:
Critically low
2024 ∙ Indiastari, D. Fajar, J. K. Tamara, F. Runesi, O. Hakim, L. N. Chotimah, K. Rahmani, A. Saputro, T. D. Afrilla, D. Firmansyah, E. Dau, D. Dzhyvak, V.
Global prevalence and determinants associated with the acceptance of monkeypox vaccination
All age groups Mpox Acceptance
Rating:
Not applicable
Loading...